China's Role in International Cardiology

Journal of the American College of Cardiology

Volumn 48, Issue 1, 2006, Pages 224-225

  Cheng, Tsung O ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; METOPROLOL;

ACUTE HEART INFARCTION; CARDIOLOGY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHINA; CLINICAL TRIAL; HEALTH CARE ORGANIZATION; HUMAN; LETTER; METABOLIC DISORDER; OBESITY; PREVALENCE; PRIORITY JOURNAL; RESEARCH SUBJECT; RISK ASSESSMENT; RURAL POPULATION; TREATMENT OUTCOME; URBAN POPULATION;

CARDIOLOGY; CARDIOVASCULAR DISEASES; CHINA; FEMALE; HUMANS; MALE; WORLD HEALTH;

EID: 33745284526     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.04.020     Document Type: Letter

References (8)

1. DeMaria A.N. Editors page. international cardiology. J Am Coll Cardiol 46 (2005) 1580-1581
2. Cheng T.O. The current state of cardiology in China. Int J Cardiol 96 (2004) 425-439
3. Cheng T.O. Metabolic syndrome in China. Circulation 109 (2004) e180
4. Cheng T.O. The metabolic syndrome, formerly called metabolic 'syndrome X'. Am J Cardiol 94 (2004) 148-149
5. Cheng TO. Obesity is the newest health risk in modern China. Lancet 2005. Available at: http://www.thelancet.com/journals/lancet/article/PIIS0140673605673448/comments?actio. Accessed October 7, 2005.
6. He J., Gu D., Wu X., et al. Major causes of death among men and women in China. N Engl J Med 353 (2005) 1124-1134
7. COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative Group. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction. randomized placebo-controlled trial. Lancet 366 (2005) 1607-1621
8. Cheng T.O., and Paul D. White Lecture. Cardiology in People's Republic of China. In: Russek H.I. (Ed). New Horizons in Cardiovascular Practice (1975), University Park Press, Baltimore, MD 1-27